Sign in

Patient Square Capital LP

CIK:0001819257
Private Equity
$12B AUM
19 holdings
Menlo Park, CA, United States
Founded:2020
77 employees
Latest filing:Jun 30, 2025

Patient Square Capital LP is a purpose-built, healthcare-focused investment firm headquartered in Menlo Park, California, United States. Founded in 2020, the firm partners with management teams whose products, services, and technologies improve health. The firm comprises a team of seasoned industry executives and investors with approximately 77 employees as of March 2025. Patient Square Capital serves institutional investors, management teams, and portfolio companies across the healthcare sector.

Investment Strategy

Patient Square Capital employs a focused, patient-centric investment approach within the healthcare sector. The firm leverages deep industry expertise, a broad network of relationships, and a true partnership model to invest in companies poised for long-term growth. Prioritizing companies improving patient lives, the firm seeks to drive value through operational excellence, growth initiatives, and strategic partnerships, always keeping patients at the center of their decision-making process.

Top Buys
A
ARGXARGENX SE - ADR
+$16.0M
R
ROIVROIVANT SCIENCES LTD.
+$14.7M
I
INSMINSMED INC
+$10.9M
E
EYPTEYEPOINT PHARMACEUTICALS, INC.
+$4.7M
K
KYMRKYMERA THERAPEUTICS, INC.
+$2.2M
Top Sells
L
LQDALIQUIDIA CORPORATION
-$9.7M
B
BPMCBLUEPRINT MEDICINES CORPORATION
-$3.4M
N
NTLAINTELLIA THERAPEUTICS, INC.
-$1.7M
S
SLNOSOLENO THERAPEUTICS, INC.
-$1.3M
N
NRIXNURIX THERAPEUTICS, INC.
-$617.8K

Top Holdings

R
ROIVROIVANT SCIENCES LTD.
+50.7%$140.6M
I
INSMINSMED INC
+13.0%$36.1M
A
ARGXARGENX SE - ADR
+5.8%$16.0M
E
EYPTEYEPOINT PHARMACEUTICALS, INC.
+4.6%$12.7M
L
LQDALIQUIDIA CORPORATION
+4.6%$12.7M

Equity Positions (19)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
R
ROIV
ROIVANT SCIENCES LTD.50.71%$140.6M12,480,000$9.01$11.27+$14.7M
I
INSM
INSMED INC13.02%$36.1M358,800$73.92$100.64+$10.9M
A
ARGX
ARGENX SE - ADR5.76%$16.0M29,000$551.22$551.22+$16.0M
E
EYPT
EYEPOINT PHARMACEUTICALS, INC.4.59%$12.7M1,352,837$7.85$9.41+$4.7M
L
LQDA
LIQUIDIA CORPORATION4.58%$12.7M1,020,000$14.92$12.46-$9.7M

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+81.8%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+13.6%
LABORATORY ANALYTICAL INSTRUMENTS
+4.6%
BLANK CHECKS
+1.4%